17.11.2025, 10:01

SPH Notification for sale of treasury shares

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on November 12, 2025 the Company sold 500 (five hundred) treasury shares representing 0.0001% of the share capital of the Company, at a total value of BGN 1 360.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.72.
The total number of treasury shares after this transaction is 19 306 015 representing 3.58% of the share capital of the Company.

Załączniki

Pobierz załącznik 1

Inne komunikaty

Data	Tytuł	Kurs
2025-12-05	SPH Minutes of the Extraordinary General Meeting of shareholfers of "Sopharna" AD held on 5 December 2025	12,75
2025-12-05	SPH Corrected notification on the terms and conditions for distribution of the dividend voted at the Extraordinary General Meeting of Shareholders of "Sopharma" AD held on December 05, 2025	12,75
2025-12-05	SPH Notification on the terms and conditions for distribution of the dividend voted at the Extraordinary General Meeting of Shareholders of "Sopharma" AD held on December 05, 2025	12,75
2025-12-05	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD	12,75
2025-12-04	SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD	12,75
2025-12-04	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD	12,75
2025-12-04	SPH Notification for sale of treasury shares	12,75
2025-12-03	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD	12,75
2025-12-03	SPH Notification for sale of treasury shares	12,75
2025-12-02	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,75

Wszystke komunikaty